Sundar Jagannath Reveals Promising CARTITUDE-1 Results

Source: Sundar Jagannath Shares Long-Term CARTITUDE-1 Results on CAR T-Cell Therapy for Multiple Myeloma - Mount Sinai Department of Medicine (2025-06-28)

Sundar Jagannath has shared encouraging long-term results from the CARTITUDE-1 clinical trial, which focuses on CAR T-cell therapy for treating multiple myeloma. The findings highlight the potential of this innovative treatment to improve patient outcomes and offer new hope for those battling this blood cancer. The update comes from Mount Sinai's Department of Medicine and underscores the ongoing advancements in immunotherapy. As research continues, these promising results could pave the way for broader adoption of CAR T-cell therapy in multiple myeloma management.

More recent coverage

• Dua Lipa and Callum Turner Still Not Planning Wedding
• Taiwan Urges Chinese Immigrants to Confirm Household Status
• Reza Pahlavi Urged to Reorganize and Engage Regionally
• Poker Face's "The Big Pump" Guest Stars Revealed
• Norwegian Crown Princess's Son Faces Serious Charges
• India's Genetic Diversity Unveiled in Landmark Study
• Katy Perry and Orlando Bloom Call Off Engagement